TY  - JOUR
AU  - Cortés-Vicente, Elena
AU  - Álvarez-Velasco, Rodrigo
AU  - Pla-Junca, Francesc
AU  - Rojas-Garcia, Ricard
AU  - Paradas, Carmen
AU  - Sevilla, Teresa
AU  - Casasnovas, Carlos
AU  - Gómez-Caravaca, María Teresa
AU  - Pardo, Julio
AU  - Ramos-Fransi, Alba
AU  - Pelayo-Negro, Ana Lara
AU  - Gutiérrez-Gutiérrez, Gerardo
AU  - Turon-Sans, Janina
AU  - López de Munain, Adolfo
AU  - Guerrero-Sola, Antonio
AU  - Jericó, Ivonne
AU  - Martín, María Asunción
AU  - Mendoza, María Dolores
AU  - Morís, Germán
AU  - Vélez-Gómez, Beatriz
AU  - Garcia-Sobrino, Tania
AU  - Pascual-Goñi, Elba
AU  - Reyes-Leiva, David
AU  - Illa, Isabel
AU  - Gallardo, Eduard
PY  - 2022
DO  - 10.1002/acn3.51492
UR  - http://hdl.handle.net/10668/19730
T2  - Annals of clinical and translational neurology
AB  - To describe the clinical characteristics and outcomes in patients with refractory myasthenia gravis (MG) and to determine the effectiveness and side effects of the drugs used for their treatment. This observational retrospective cross-sectional...
LA  - en
KW  - Adult
KW  - Aged
KW  - Cross-Sectional Studies
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Immunologic Factors
KW  - Male
KW  - Middle Aged
KW  - Myasthenia Gravis
KW  - Outcome Assessment, Health Care
KW  - Registries
KW  - Retrospective Studies
KW  - Spain
TI  - Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome.
TY  - research article
VL  - 9
ER  -